TickerFacts.

Bioventus Inc. (BVS): Revenue

Annual figures by period end, from SEC filings.

$568.09M
Year ended 2025-12-31
$581.85M
Trailing 12 months to 2026-06-27
+3.5%
3-year compound annual growth
+12.1%
5-year compound annual growth
$573.28M2019-12-31: $340.14M2020-12-31: $321.16M2021-12-31: $430.90M2022-12-31: $512.12M2023-12-31: $512.35M2024-12-31: $573.28M2025-12-31: $568.09M$568.09M
2019-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$568.09M-0.9%2026-03-05, From 2025-01-01
2024-12-31$573.28M+11.9%2026-03-05, From 2024-01-01
2023-12-31$512.35M0.0%2026-03-05, From 2023-01-01
2022-12-31$512.12M+18.8%2025-03-11, From 2022-01-01
2021-12-31$430.90M+34.2%2024-03-12, From 2021-01-01
2020-12-31$321.16M-5.6%2023-03-31, From 2020-01-01
2019-12-31$340.14Mn/a2022-03-11, From 2019-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Bioventus Inc. (BVS)2025-12-31$568.09M-0.9%
UFP Technologies Inc (UFPT)2025-12-31$602.80M+19.5%
AtriCure, Inc. (ATRC)2025-12-31$534.53M+14.9%
Glaukos Corp (GKOS)2025-12-31$507.44M+32.3%
NovoCure Ltd (NVCR)2025-12-31$655.35M+8.3%
Artivion, Inc. (AORT)2025-12-31$441.33M+13.6%
iRhythm Holdings, Inc. (IRTC)2025-12-31$747.14M+26.2%
Alphatec Holdings, Inc. (ATEC)2025-12-31$764.15M+25.0%
Mimedx Group, Inc. (MDXG)2025-12-31$418.63M+20.0%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗